Comparison of Efficacy, Safety and Tolerability of Two Different 810 nm Diode Lasers for Hair Reduction
Primary Purpose
Hypertrichosis
Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Soprano/SHR
LightSheer
Sponsored by
About this trial
This is an interventional treatment trial for Hypertrichosis focused on measuring Hair removal, Laser, Diode laser
Eligibility Criteria
Inclusion Criteria:
- Subjects must be at least 18 years of age.
- Subjects must be in reasonably good health as defined by the Investigator.
- Subject agrees to avoid tanning during their participation in this trial.
- Subject has Fitzpatrick skin types I-V and dark brown hair.
- Subjects must agree to avoid shaving legs less than 72 hours prior to a study visit.
- Subjects have indicated willingness to participate in the study by signing an informed consent document.
Exclusion Criteria:
- Subject is pregnant, lactating, or planning to get pregnant within the study period.
- Subject is unwilling to use birth control during the study period if of child bearing age.
- Subject has a known history of photosensitivity or use of medication with photosensitizing properties.
- Subject has skin disease on exam at screening.
- Subject has history or evidence of any chronic or reoccurring skin disease or disorder(e.g., psoriasis, Netherton syndrome, etc.) affecting the treatment area.
- Subject has a history of keloid or hypertrophic scar formation.
- Subject has a tattoo in the treatment area.
- Subject has been tanning within the past 30 days.
- Subject has history of confounding cancerous or pre-cancerous skin lesions in the treatment area.
- Subject has used prohibited therapies (electrolysis, threading, waxing, depilatory), prohibited oral prescription medications (isotretinoin, steroids), or prohibited topical meds (steroids) on the treatment area within 30 days prior to enrollment.
- Subject is unwilling to discontinue use of above listed prohibitive therapies for the duration of treatment.
- Subject has a history of laser hair removal in the treatment area.
- Subject has participated in any clinical trial involving an investigational drug or cosmetic product or procedure within the past 30 days.
The investigator feels that for any reason the subject is not eligible to participate in the study.
-
Sites / Locations
- Department of Dermatology Clinical Research
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Soprano/SHR
LightSheer
Arm Description
Alma Soprano/SHR 810 nm Diode Laser
LightSheer Duet 810 nm diode laser
Outcomes
Primary Outcome Measures
Change in Hair Growth
% reduction from baseline hair count at time points 1 month, 6 months and 12 months [following last (5th laser) treatment]
Secondary Outcome Measures
Pain Rating Scale
Pain during each treatment was measured subjectively by patients on a 0-10 visual analogue scale (0=no pain, 10=unbearable pain).
Full Information
NCT ID
NCT01212172
First Posted
September 22, 2010
Last Updated
January 7, 2016
Sponsor
University of California, Irvine
1. Study Identification
Unique Protocol Identification Number
NCT01212172
Brief Title
Comparison of Efficacy, Safety and Tolerability of Two Different 810 nm Diode Lasers for Hair Reduction
Official Title
Side-by-Side Comparison of 810 nm Diode Laser Technology With Low Fluence-High Repetition Rate vs Low Fluence-Vacuum Assist - A Split - Extremity Efficacy , Safety and Tolerability Study
Study Type
Interventional
2. Study Status
Record Verification Date
October 2015
Overall Recruitment Status
Completed
Study Start Date
September 2010 (undefined)
Primary Completion Date
September 2013 (Actual)
Study Completion Date
September 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, Irvine
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this research study is to compare two different 810 diode laser systems (Soprano XL (SHR Mode)and Light Sheer Duet) for laser hair removal. The goal is to determine if each laser system is effective at reducing the amount of hair on the lower legs or the axilla (arm pit). Another goal is determine the subject's perspective on the treatment including tolerability and effectiveness.
Detailed Description
This side-by-side split body, blinded, randomized single-center study is comparing two different 810 nm diode laser technologies for the purpose of permanent hair reduction to determine the effectiveness and subject's tolerance for hair reduction. Twenty volunteers will be enrolled into this study. Subjects will receive a total of 5 treatments of either axilla or lower legs. 10 patients will have both axilla treated while the other 10 subjects will have the lower legs treated. Placement to the axilla treatment group vs. the lower leg treatment group is random.
Treatment areas will be randomized to receive Soprano SHR treatment or Light Sheer/Duet treatment. One extremity (example: right axilla) will receive Soprano SHR treatment and the contra-lateral extremity (example: left axilla) will receive Duet treatment. The treatments will occur every 6 - 8 weeks and then there will be follow up visits at 1 month, 6 months, and 12 months after the last treatment.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertrichosis
Keywords
Hair removal, Laser, Diode laser
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Soprano/SHR
Arm Type
Active Comparator
Arm Description
Alma Soprano/SHR 810 nm Diode Laser
Arm Title
LightSheer
Arm Type
Active Comparator
Arm Description
LightSheer Duet 810 nm diode laser
Intervention Type
Device
Intervention Name(s)
Soprano/SHR
Other Intervention Name(s)
Soprano/SHR laser
Intervention Description
For the Soprano, the constant motion technique will be used with a fluence ranging between 6 J/cm2 and 10 J/cm2, 10 Hz, 20 ms pulse duration. The constant motion technique involves treating 100 cm2 areas with multiple passes until reaching the cumulative energy dose of 8 kJ. Thus, the hand piece is kept in constant motion to deliver continuous low fluence that will build up energy over time.
Intervention Type
Device
Intervention Name(s)
LightSheer
Other Intervention Name(s)
Duet LightSheer
Intervention Description
The LightSheer/Duet will be used with conventional single pass (stamping) of the handpiece using settings of single pulse fluence of up to 14 J/cm2 and low vacuum settings.
Primary Outcome Measure Information:
Title
Change in Hair Growth
Description
% reduction from baseline hair count at time points 1 month, 6 months and 12 months [following last (5th laser) treatment]
Time Frame
1 month, 6 month, 12 month
Secondary Outcome Measure Information:
Title
Pain Rating Scale
Description
Pain during each treatment was measured subjectively by patients on a 0-10 visual analogue scale (0=no pain, 10=unbearable pain).
Time Frame
12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Subjects must be at least 18 years of age.
Subjects must be in reasonably good health as defined by the Investigator.
Subject agrees to avoid tanning during their participation in this trial.
Subject has Fitzpatrick skin types I-V and dark brown hair.
Subjects must agree to avoid shaving legs less than 72 hours prior to a study visit.
Subjects have indicated willingness to participate in the study by signing an informed consent document.
Exclusion Criteria:
Subject is pregnant, lactating, or planning to get pregnant within the study period.
Subject is unwilling to use birth control during the study period if of child bearing age.
Subject has a known history of photosensitivity or use of medication with photosensitizing properties.
Subject has skin disease on exam at screening.
Subject has history or evidence of any chronic or reoccurring skin disease or disorder(e.g., psoriasis, Netherton syndrome, etc.) affecting the treatment area.
Subject has a history of keloid or hypertrophic scar formation.
Subject has a tattoo in the treatment area.
Subject has been tanning within the past 30 days.
Subject has history of confounding cancerous or pre-cancerous skin lesions in the treatment area.
Subject has used prohibited therapies (electrolysis, threading, waxing, depilatory), prohibited oral prescription medications (isotretinoin, steroids), or prohibited topical meds (steroids) on the treatment area within 30 days prior to enrollment.
Subject is unwilling to discontinue use of above listed prohibitive therapies for the duration of treatment.
Subject has a history of laser hair removal in the treatment area.
Subject has participated in any clinical trial involving an investigational drug or cosmetic product or procedure within the past 30 days.
The investigator feels that for any reason the subject is not eligible to participate in the study.
-
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christopher B Zachary, MBBS, FRCP
Organizational Affiliation
University of California, Irvine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Dermatology Clinical Research
City
Irvine
State/Province
California
ZIP/Postal Code
92697
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Comparison of Efficacy, Safety and Tolerability of Two Different 810 nm Diode Lasers for Hair Reduction
We'll reach out to this number within 24 hrs